More than 3.4 billion people, nearly half the world's population, own at least one mobile phone in 2013. As of 2010, more than 90 percent of people worldwide were covered by a mobile phone signal, according to a new Vital Signs Online trend ...
Tags: Mobile Phone, Consumer Electronics
Medical device company EndoStim has announced that Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) approved its lower esophageal sphincter (LES) stimulation system for gastroesophageal reflux disease ...
Tags: Medical device, Gerd Treatment
Atheris Laboratories and Debiopharm have announced the signature of a collaboration agreement regarding the Atheris 'Reverse-Discovery' lead optimization platform. Collaboration with Atheris is expected to accelerate Debiopharm's ongoing ...
Cervel Neurotech has initiated a clinical study for patients suffering from treatment resistant depression at seven leading academic and research centers in the US. The 80-patient trial, designed as a randomized, sham-controlled, double ...
Health Canada has released a revised labeling information for acetylsalicylic acid (ASA) products for use in adults and children of ages 12 years and older. The information will enable people of Canada to choose the right pain or fever ...
Using LED light sources as a medium for light therapy devices can stimulate the human body’s metabolism rate and greatly reduce medical risks associated to conventional light therapy, such as laser and intense pulse light, said Simon ...
Tags: LED Light, Lower Treatment Risks
Lighting Science launched Definity Digital™, the world’s first line of biologically-corrected lighting with products specifically designed to improve sleep, support natural melatonin production, boost alertness, accelerate plant ...
Tags: Lighting Science, LED Lighting
US-based development-stage biopharmaceutical firm Sorrento Therapeutics has acquired Sherrington Pharmaceuticals (Sherrington), a company that provides chronic pain treatment for end-stage cancer patients and other severe pain indications. ...
Tags: Drug, Chronic Pain Treatment
These days, the government is cracking down real hard on companies which don't confirm to environmental standards. Every single nut, bolt and oil that you use in your factory has to confirm to the standards, else your company could be ...
Optivia Biotechnology has secured a $1.8m two-year Phase II small business innovation research (SBIR) grant, from the National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH). The federal grant is expected to ...
Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
Canadian regulatory authority Health Canada has approved Valeant Pharmaceuticals International subsidiary Valeant Canada's new drug submission of Jublia for the treatment of onychomycosis. Jublia is designated for the treatment of mild to ...
Tags: Fungal Drug, Medicine
CYou will feel relaxed and comfortable with the herbal flower tea... What a good thing it is to enjoy the rare flower tea with a favorite book or a couple of bosom friends! With the boredom that can come from city living, a person will ...
Tags: Herbal Flower Tea, Tea, Agriculture, Food
Swiss drugmaker F. Hoffmann-La Roche has announced that the EU’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending authorization of Kadcyla as a single agent for the treatment of adult ...
Tags: Breast Cancer Drug
SeaChange Pharmaceuticals has introduced its similarity ensemble approach (SEA) software called SEAware for predictive matching of drugs with disease and toxicity targets. SEAware provides analysis and visualization tools for prediction ...